Dhawaan, JYMed Technology Co., Ltd. ayaa ku dhawaaqday in Leuprorelin Acetate, oo ay soo saartay xarunteeda Hubei JX Bio-Pharmaceutical Co., Ltd., ayaa si guul leh u gudubtay kormeerka diiwaangelinta daroogada.
Guudmarka Suuqa Dawooyinka Asalka ah
Leuprorelin Acetate waa daawo la isku duro oo loo isticmaalo daawaynta cudurada hormoonka ku tiirsan, oo leh caanaha molecular C59H84N16O12•xC2H4O2. Waa gonadotropin-sii daynta hoormoonka agonist (GnRHa) kaas oo ka shaqeeya joojinta nidaamka pituitary-gonadadal. Asal ahaan waxaa iska kaashaday AbbVie iyo Takeda Pharmaceutical, dawadan waxaa lagu suuq geeyaa magacyo kala duwan oo dalal kala duwan ah. Dalka Mareykanka, waxaa lagu iibiyaa magaca astaanta ah ee LUPRON DEPOT, halka Shiinaha, loo suuqgeeyo sida Yina Tong.
Habka cad iyo doorarka si wanaagsan loo qeexay
Laga soo bilaabo 2019 ilaa 2022, cilmi baarista dawooyinka iyo horumarinta ayaa la dhammaystiray, oo ay ku xigto diiwaangelinta API-ga Maarso 2024, markii ogeysiiska aqbalaadda la helay. Kormeerka diiwaangelinta daroogada ayaa la ansixiyay Agoosto 2024. JYMed Technology Co., Ltd. ayaa mas'uul ka ah horumarinta habka, horumarinta habka falanqaynta, daraasaadka wasakhda, xaqiijinta qaabdhismeedka, iyo habka ansixinta. Hubei JX Bio-Pharmaceutical Company
Baahinta Suuqa iyo Koritaanka Baahida
Kor u kaca dhacdooyinka kansarka qanjirka 'prostate' iyo fibroids uterineine waxay keenaysaa baahida korodhka ah ee Leuprorelin Acetate. Suuqa Waqooyiga Ameerika wuxuu hadda xukumaa suuqa Leuprorelin Acetate, oo leh kharashaadka daryeelka caafimaadka ee sii kordhaya iyo aqbalaadda sare ee tignoolajiyada cusub ayaa ah darawallada kobaca aasaasiga ah. Isla mar ahaantaana, suuqa Aasiya, gaar ahaan Shiinaha, ayaa sidoo kale muujinaya baahida xooggan ee Leuprorelin Acetate. Wax ku oolkeeda awgeed, baahida caalamiga ah ee daawadan ayaa kor u sii kacaysa, iyadoo cabbirka suuqa la filayo inuu gaaro USD 3,946.1 milyan marka la gaaro 2031, taasoo ka tarjumaysa kobaca sanadlaha ah ee isku dhafka ah (CAGR) ee 4.86% laga bilaabo 2021 ilaa 2031.
Ku saabsan JYMed
Shenzhen JYMed Technology Co., Ltd. (hadda dambe loo yaqaan JYMed) waxaa la aasaasay 2009, ku takhasusay cilmi-baarista, horumarinta, wax soo saarka, iyo iibinta peptides iyo peptide la xiriira alaabta. Iyada oo leh hal xarun cilmi baaris iyo saddex saldhig oo wax soo saar oo waaweyn, JYMed waa mid ka mid ah soosaarayaasha ugu weyn ee API-yada kiimikaad lagu farsameeyey ee peptide ee Shiinaha. Kooxda R&D ee xudunta u ah shirkadu waxay ku faantaa in ka badan 20 sano oo waayo-aragnimo ah warshadaha peptide waxayna si guul leh uga gudubtay baaritaannada FDA laba jeer. Nidaamka warshadaynta peptide ee dhamaystiran oo hufan ee JYMed waxay siisaa macaamiisha adeegyo kala duwan oo buuxa, oo ay ku jiraan horumarinta iyo soosaarka peptides-daweynta, peptides-ka caafimaadka xoolaha, peptides antimicrobial, iyo peptides-ka qurxinta, iyo sidoo kale diiwaangelinta iyo taageerada sharciyeynta.
Hawlaha Ganacsiga ee ugu muhiimsan
1.Diiwaan galinta gudaha iyo dibada ee peptide APIs
2. peptides-ka caafimaadka xoolaha iyo kuwa la isku qurxiyo
3.Custom peptides iyo CRO, CMO, adeegyada OEM
4.PDC (peptide-radionuclide, peptide-small molecule, peptide-protein, peptide-RNA)
Marka laga soo tago Leuprorelin Acetate, JYMed waxay soo gudbisay diiwaan gelinta FDA iyo CDE dhowr alaab oo API ah, oo ay ku jiraan dawooyinka fasalka GLP-1RA ee hadda caanka ah sida Semaglutide, Liraglutide iyo Tirzepatide. Macaamiisha mustaqbalka ee isticmaalaya alaabta JYMed waxay awood u yeelan doonaan inay si toos ah u tixraacaan lambarka diiwaangelinta CDE ama lambarka faylka DMF marka ay soo gudbinayaan codsiyada diiwaangelinta FDA ama CDE. Tani waxay si weyn u dhimi doontaa wakhtiga loo baahan yahay diyaarinta dukumentiyada codsiga, iyo sidoo kale wakhtiga qiimaynta iyo qiimaha dib u eegista alaabta.
Nala Soo Xidhiidh
Shenzhen JYMed Technology Co., Ltd.
Cinwaanka:Dabaqyada 8aad & 9aad, Dhismaha 1, Shenzhen Innovation Innovation Industrial Park, No. 14 Jidka Jinhui, Xaafada Kengzi, Degmada Pingshan, Shenzhen
Taleefanka:+86 755-26612112
Mareegta:http://www.jymedtech.com/
Waqtiga boostada: Agoosto-29-2024